Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results

被引：19
作者：
Cebeci, Filiz [1 ]
Kartal, Ilkay [2 ]
机构：
[1] Istanbul Medeniyet Univ, Dept Dermatol, Istanbul, Turkey
[2] Istanbul Medeniyet Univ, Dept Endocrinol, Istanbul, Turkey
来源：
EUROPEAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 30卷 / 01期
关键词：
D O I：
10.1136/ejhpharm-2021-002794
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 8 条
[1]  
ACR COVID-19 Vaccine Clinical Guidance Task Force, 2021, COVID 19 VACC CLIN G
[2]   Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection [J].
Diaz-Guimaraens, Borja ;
Dominguez-Santas, Miguel ;
Suarez-Valle, Ana ;
Pindado-Ortega, Cristina ;
Selda-Enriquez, Gerald ;
Bea-Ardebol, Sonia ;
Fernandez-Nieto, Diego .
JAMA DERMATOLOGY, 2020, 156 (07) :820-822
[3]   Development of an inactivated vaccine candidate for SARS-CoV-2 [J].
Gao, Qiang ;
Bao, Linlin ;
Mao, Haiyan ;
Wang, Lin ;
Xu, Kangwei ;
Yang, Minnan ;
Li, Yajing ;
Zhu, Ling ;
Wang, Nan ;
Lv, Zhe ;
Gao, Hong ;
Ge, Xiaoqin ;
Kan, Biao ;
Hu, Yaling ;
Liu, Jiangning ;
Cai, Fang ;
Jiang, Deyu ;
Yin, Yanhui ;
Qin, Chengfeng ;
Li, Jing ;
Gong, Xuejie ;
Lou, Xiuyu ;
Shi, Wen ;
Wu, Dongdong ;
Zhang, Hengming ;
Zhu, Lang ;
Deng, Wei ;
Li, Yurong ;
Lu, Jinxing ;
Li, Changgui ;
Wang, Xiangxi ;
Yin, Weidong ;
Zhang, Yanjun ;
Qin, Chuan .
SCIENCE, 2020, 369 (6499) :77-+
[4]   Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report [J].
Mayor-Ibarguren, A. ;
Feito-Rodriguez, M. ;
Quintana Castanedo, L. ;
Ruiz-Bravo, E. ;
Montero Vega, D. ;
Herranz-Pinto, P. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (10) :E541-E542
[5]   Vaccine-associated hypersensitivity [J].
McNeil, Michael M. ;
DeStefano, Frank .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) :463-472
[6]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[7]   Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial [J].
Wu, Zhiwei ;
Hu, Yaling ;
Xu, Miao ;
Chen, Zhen ;
Yang, Wanqi ;
Jiang, Zhiwei ;
Li, Minjie ;
Jin, Hui ;
Cui, Guoliang ;
Chen, Panpan ;
Wang, Lei ;
Zhao, Guoqing ;
Ding, Yuzhu ;
Zhao, Yuliang ;
Yin, Weidong .
LANCET INFECTIOUS DISEASES, 2021, 21 (06) :803-812
[8]   Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial [J].
Zhang, Yanjun ;
Zeng, Gang ;
Pan, Hongxing ;
Li, Changgui ;
Hu, Yaling ;
Chu, Kai ;
Han, Weixiao ;
Chen, Zhen ;
Tang, Rong ;
Yin, Weidong ;
Chen, Xin ;
Hu, Yuansheng ;
Liu, Xiaoyong ;
Jiang, Congbing ;
Li, Jingxin ;
Yang, Minnan ;
Song, Yan ;
Wang, Xiangxi ;
Gao, Qiang ;
Zhu, Fengcai .
LANCET INFECTIOUS DISEASES, 2021, 21 (02) :181-192
1